{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19657315", "DateCompleted": {"Year": "2009", "Month": "11", "Day": "03"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1097/MBC.0b013e32831c4cb0"], "Journal": {"ISSN": "1473-5733", "JournalIssue": {"Volume": "20", "Issue": "3", "PubDate": {"Year": "2009", "Month": "Apr"}}, "Title": "Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis", "ISOAbbreviation": "Blood Coagul Fibrinolysis"}, "ArticleTitle": "The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.", "Pagination": {"StartPage": "185", "EndPage": "190", "MedlinePgn": "185-90"}, "Abstract": {"AbstractText": ["Ankaferd comprises a standardized mixture of plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum and Urtica dioica. Ankaferd Blood Stopper (ABS) as a medicinal product has been approved in the management of external hemorrhage and dental surgery bleedings in Turkey. This study aimed to evaluate the in-vivo hemostatic effect of ABS in rats pretreated with acetylsalicylic acid or enoxaparin. Wistar rats (210-270 g) of both sexes were used in this study. The animals were pretreated with acetylsalicylic acid (10 mg/kg) orally for 4 days or enoxaparin sodium (8 mg/kg) subcutaneously for 3 days or did not receive any anticoagulant before tail cut at 4th day. ABS was administered topically [a total of 4 ml (1 ml/puff x 4)] to the cut tail in the studied animals. The duration of bleeding and the amount of bleeding were measured in order to evaluate the hemostatic effect of ABS. In acetylsalicylic acid-treated animals, topical ABS reduced both the duration and also the amount of bleeding volume by 68.4 and 54.6%, respectively. It was also effective in shortening the duration of bleeding (30.6%) and decreasing the amount of bleeding (32.8%) in enoxaparin-treated animals. ABS, a traditional folkloric medicinal plant extract, has in-vivo hemostatic actions, which may provide a therapeutic potential for the management of patients with deficient hemostasis in the clinical medicine."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology, Faculty of Medicine, University of Fatih, Istanbul, Turkey."}], "Identifier": [], "LastName": "Kosar", "ForeName": "Ali", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cipil", "ForeName": "Handan S", "Initials": "HS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kaya", "ForeName": "Arif", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Uz", "ForeName": "Burak", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Haznedaroglu", "ForeName": "Ibrahim C", "Initials": "IC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Goker", "ForeName": "Hakan", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ozdemir", "ForeName": "Oktay", "Initials": "O"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ercetin", "ForeName": "Sevil", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kirazli", "ForeName": "Serafettin", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Firat", "ForeName": "Huseyin Cahit", "Initials": "HC"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Blood Coagul Fibrinolysis", "NlmUniqueID": "9102551", "ISSNLinking": "0957-5235"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticoagulants"}, {"RegistryNumber": "0", "NameOfSubstance": "Enoxaparin"}, {"RegistryNumber": "0", "NameOfSubstance": "Hemostatics"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "ankaferd blood stopper"}, {"RegistryNumber": "R16CO5Y76E", "NameOfSubstance": "Aspirin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Analysis of Variance"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anticoagulants"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Aspirin"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enoxaparin"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["blood", "drug therapy", "etiology"], "DescriptorName": "Hemorrhage"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemostasis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hemostatics"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Lacerations"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "8", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "8", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "11", "Day": "5", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19657315", "10.1097/MBC.0b013e32831c4cb0", "00001721-200904000-00004"]}}], "PubmedBookArticle": []}